Molecular dissection of the signaling and costimulatory functions of CD150 (SLAM): CD150/SAP binding and CD150-mediated costimulation
Open Access
- 1 February 2002
- journal article
- Published by American Society of Hematology in Blood
- Vol. 99 (3) , 957-965
- https://doi.org/10.1182/blood.v99.3.957
Abstract
CD150 signaling lymphocytic activation molecule (SLAM), a T/B/dendritic cell surface glycoprotein, is a costimulatory receptor involved in T-cell activation and is also a receptor for measles virus. CD150-induced signal transduction is controlled bySAP/SH2D1A, the gene that is aberrant in X-linked lymphoproliferative disease and familial hemophagocytic lymphohistiocytosis. This report shows that CD150 colocalizes with the T-cell receptor (TCR) following CD3 triggering in human peripheral blood T cells and is rapidly and reversibly tyrosine phosphorylated on TCR cross-linking. The Src-like kinases Lck and Fyn phosphorylate tyrosine residues in the cytoplasmic tail of CD150. The results demonstrate that the SAP protein has 2 modes of binding to CD150. Binding to the motif Thr-Ile-Tyr281Ala-Gln-Val occurs in a phosphotyrosine-independent fashion and to the motif Thr-Val-Tyr327Ala-Ser-Val in a phosphotyrosine-dependent manner. Within both SAP binding motifs the threonine residue at position −2 to tyrosine is essential to stabilize the interaction irrespective of tyrosine phosphorylation, a feature unique to the SAP SH2 domain. A leucine residue, Leu278, further stabilizes nonphospho binding of SAP to Tyr281 of CD150. SAP blocking of the tyrosine phosphatase SHP-2 occurs primarily on Tyr281 of CD150 because SHP-2 requires both Tyr281 and Tyr327 for binding to CD150, and SAP binds to nonphosphorylated Tyr281. CD150 exhibits lateral mobility, segregating into intercellular contacts. The lateral mobility and homophilic clustering of CD150 between neighboring cells is not dependent on SAP/CD150 interaction.Keywords
This publication has 27 references indexed in Scilit:
- Cell surface receptors Ly-9 and CD84 recruit the X-linked lymphoproliferative disease gene product SAPBlood, 2001
- Measles Viruses on Throat Swabs from Measles Patients Use Signaling Lymphocytic Activation Molecule (CDw150) but Not CD46 as a Cellular ReceptorJournal of Virology, 2001
- X-Linked Lymphoproliferative Disease: A Progressive ImmunodeficiencyAnnual Review of Immunology, 2001
- V Domain of Human SLAM (CDw150) Is Essential for Its Function as a Measles Virus ReceptorJournal of Virology, 2001
- Signaling Lymphocytic Activation Molecule (CDw150) Is Homophilic but Self-associates with Very Low AffinityPublished by Elsevier ,2000
- X-Linked Lymphoproliferative DiseaseThe Journal of Experimental Medicine, 2000
- The X-linked lymphoproliferative syndrome gene product SH2D1A associates with p62dok(Dok1) and activates NF-κBProceedings of the National Academy of Sciences, 2000
- INTEGRATION OF T CELL RECEPTOR–DEPENDENT SIGNALING PATHWAYS BY ADAPTER PROTEINSAnnual Review of Immunology, 1999
- Soluble and Membrane-bound Forms of Signaling Lymphocytic Activation Molecule (SLAM) Induce Proliferation and Ig Synthesis by Activated Human B LymphocytesThe Journal of Experimental Medicine, 1997
- A novel receptor involved in T-cell activationNature, 1995